Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The polycystin-1 C-terminal fragment triggers branching morphogenesis and migration of tubular kidney epithelial cells
Christian Nickel, … , Lloyd G. Cantley, Gerd Walz
Christian Nickel, … , Lloyd G. Cantley, Gerd Walz
Published February 15, 2002
Citation Information: J Clin Invest. 2002;109(4):481-489. https://doi.org/10.1172/JCI12867.
View: Text | PDF
Article

The polycystin-1 C-terminal fragment triggers branching morphogenesis and migration of tubular kidney epithelial cells

  • Text
  • PDF
Abstract

Mutations of either PKD1 or PKD2 cause autosomal dominant polycystic kidney disease, a syndrome characterized by extensive formation of renal cysts and progressive renal failure. Homozygous deletion of Pkd1 or Pkd2, the genes encoding polycystin-1 and polycystin-2, disrupt normal renal tubular differentiation in mice but do not affect the early steps of renal development. Here, we show that expression of the C-terminal 112 amino acids of human polycystin-1 triggers branching morphogenesis and migration of inner medullary collecting duct (IMCD) cells, and support in vitro tubule formation. The integrity of the polycystin-2–binding region is necessary but not sufficient to induce branching of IMCD cells. The C-terminal domain of polycystin-1 stimulated protein kinase C-α (PKC-α), but not the extracellular signal–regulated kinases ERK1 or ERK2. Accordingly, inhibition of PKC, but not ERK, prevented polycystin-1–mediated IMCD cell morphogenesis. In contrast, HGF-mediated morphogenesis required ERK activation but was not dependent on PKC. Our findings demonstrate that the C-terminal domain of polycystin-1, acting in a ligand-independent fashion, triggers unique signaling pathways for morphogenesis, and likely plays a central role in polycystin-1 function.

Authors

Christian Nickel, Thomas Benzing, Lorenz Sellin, Peter Gerke, Anil Karihaloo, Zhen-Xiang Liu, Lloyd G. Cantley, Gerd Walz

×

Figure 10

Options: View larger image (or click on image) Download as PowerPoint
Polycystin-1–mediated branching morphogenesis and migration are abrogate...
Polycystin-1–mediated branching morphogenesis and migration are abrogated by inhibition of PKC activity. (a) IMCD cells, transduced with a retrovirus expressing CD16.7.PKD1, were treated with the nonspecific PKC inhibitors staurosporine (Stauro; 100 pM) or calphostin C (Cal C; 100 nM) for 24 hours. Both inhibitors completely abrogated polycystin-1–mediated branching of IMCD cells (n = 3). The selective PKC inhibitor bis-indolylmaleimide I (Bis I, 5 μM), but not the inactive isomer bis-indolylmaleimide V (Bis V, 5 μM), similarly inhibited polycystin-1–mediated branching of IMCD cells. (b) Gö6976, a selective inhibitor of the calcium-dependent α, β, and δ PKC isoforms, abrogates polycystin-1–dependent branching morphogenesis in a dose-dependent fashion. (c) Gö6976 (1 μM) inhibits polycystin-1–mediated migration. (d) IMCD cells expressing CD16.7 or CD16.7.PKD1 were treated with either Gö6976, HGF, or both reagents. Gö6976 (1 μM) inhibited the polycystin-1–mediated branching, but had no effect on basal branching. Treatment with HGF increased IMCD cell branching, and had an additive effect on polycystin-1–mediated branching. Gö6976 failed to prevent HGF-mediated branching.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts